Comparison of two treatment modalities for managing oral lichen planus.

Not Applicable

Completed

• Conditions: lichen planus; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12622001424796
• Lead Sponsor: Damascus University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-07-12
• Study Start: 2022-11-08
• Last Update Posted: 14 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Patients with bilateral, symptomatic oral lichen planus which are clinically and histologically confirmed.

Exclusion Criteria

Presence of dysplasia on histological examination, the presence of co-occurring skin and/or genital lesions, receiving topical treatment for oral lichen planus (OLP) in the past 4 weeks, a history of steroids allergy, pregnant or lactating women, lichen-like lesions (systematic use of drugs that can cause lichenoid reactions, graft versus host disease), consumption of systematic drugs that may interfere with the treatment (steroids, immunosuppressive drugs, retinoids) during the past 6 months, and patients with uncontrolled systematic disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified